Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NuPathe Must Patch Together New Zelrix Launch Timetable After "Complete Response" Letter

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA had questions related to chemistry, manufacturing and safety of migraine patch, company said.
Advertisement

Related Content

Zecuity Redesign Got Migraine Patch Through FDA, But Burning Continued
Teva Zecuity's Safety: Burns Go From Non-Issue In Label To Product Puller
Allergan/MAP Planned Merger, Approval Of NuPathe’s Triptan Patch Change U.S. Landscape For Migraine Therapy
Migraine Snapshot: Despite Significant Generic Presence, MAP, Allergan, Others See Big Market Potential
Drug Patch Manufacturers Can Skip Quality By Design Approach, FDA Says
Drug Patch Manufacturers Can Skip Quality By Design Approach, FDA Says
Second Intermezzo "Complete Response" Threatens Transcept's Partnership Payments
Allergan And MAP Team Up On Inhalable Migraine Treatment

Topics

Advertisement
UsernamePublicRestriction

Register

PS072713

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel